Table 1.
Lentiviral vector | n | Albumin/creatinine | P |
LV-EGFP | 12 | 5.27 ± 0.74 | — |
LV-hsFLT1 | 14 | 7.47 ± 0.61 | 0.03 |
LV-hsFLT1 (PD) | 5 | 4.50 ± 0.38 | 0.52 |
LV-hsFLT1 + pravastatin | 8 | 4.06 ± 0.38 | 0.23 |
LV-hsFLT1 + LV-mPGF | 15 | 6.41 ± 0.61 | 0.24 |
Blastocysts were transduced with lentiviral vectors at 100 ng of p24/mL. Pravastatin was administered at 5 μg per body every day starting at E7.5. Urine was collected at E18.5 or 1 wk postdelivery (PD) and analyzed. Average ± SEM. Student's t test was performed against LV-EGFP treatment.